Patents by Inventor Kevin Meehan

Kevin Meehan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10413523
    Abstract: A composition which includes Phenylalanine, Serine, Glutamine and GABA (?-aminobutyric acid). The composition contains the essential amino acids Phenylalanine; Glutamine; the non-essential amino acid Serine; and GABA (?-aminobutyric acid) in concentrations effective to influence or modulate the neurotransmitter pentapeptide enkephalin. The composition may further comprise tetrahydrocannabinol (THC).
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: September 17, 2019
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan
  • Patent number: 10117101
    Abstract: The proliferation of IOT devices has led to an increase in sensitive, cloud-stored data. To provide further protection, IOT device data may be secured by geographically based access controls as a supplement to or in place of traditional password protection. A geographically based access control restricts data accessibility to designated geographical areas. In this manner, a requesting device may not access geo-fence protected IOT device data unless the requesting device is located within a designated geographical area. Geo-fence parameters utilized for creation of a geo-fence policy may be pre-specified or generated based on operating conditions. For example, a user may provide location data, such as an address or geographical coordinate, and a radial distance from the location for which data access is permissible. Additionally, geo-fence parameters can be automatically determined based on criteria such as an IOT device type or data usage characteristics.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: October 30, 2018
    Assignee: CA, Inc.
    Inventors: Dhiraj Girdhar, Kevin Meehan, Brian Christopher Peck, Dhara Shah
  • Patent number: 9937146
    Abstract: A composition which includes Phenylalanine, Serine, Glutamine and GABA (?-aminobutyric acid). The composition contains the essential amino acids Phenylalanine; Glutamine; the non-essential amino acid Serine; and GABA (?-aminobutyric acid) in concentrations effective to influence or modulate the neurotransmitter pentapeptide enkephalin. The composition may further comprise tetrahydrocannabinol (THC).
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: April 10, 2018
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan
  • Publication number: 20180071246
    Abstract: A composition which includes Phenylalanine, Serine, Glutamine and GABA (?-aminobutyric acid). The composition contains the essential amino acids Phenylalanine; Glutamine; the non-essential amino acid Serine; and GABA (?-aminobutyric acid) in concentrations effective to influence or modulate the neurotransmitter pentapeptide enkephalin. The composition may further comprise tetrahydrocannabinol (THC).
    Type: Application
    Filed: November 16, 2017
    Publication date: March 15, 2018
    Inventor: Kevin Meehan
  • Publication number: 20180042961
    Abstract: Achromotricia can begin due to a wide variety of reasons, one primarily being genetics, the IRF4 gene and exposures to various endogenous and exogenous factors. There are numerous stimuli currently recognized to influence the production of melanin by mature melanocytes. The composition presented herein recognizes the attributed principles which can influence the primary causes of achromotricia.
    Type: Application
    Filed: October 24, 2017
    Publication date: February 15, 2018
    Inventor: Kevin Meehan
  • Publication number: 20170366977
    Abstract: The proliferation of TOT devices has led to an increase in sensitive, cloud-stored data. To provide further protection, TOT device data may be secured by geographically based access controls as a supplement to or in place of traditional password protection. A geographically based access control restricts data accessibility to designated geographical areas. In this manner, a requesting device may not access geo-fence protected TOT device data unless the requesting device is located within a designated geographical area. Geo-fence parameters utilized for creation of a geo-fence policy may be pre-specified or generated based on operating conditions. For example, a user may provide location data, such as an address or geographical coordinate, and a radial distance from the location for which data access is permissible. Additionally, geo-fence parameters can be automatically determined based on criteria such as an TOT device type or data usage characteristics.
    Type: Application
    Filed: August 30, 2017
    Publication date: December 21, 2017
    Inventors: Dhiraj Girdhar, Kevin Meehan, Brian Christopher Peck, Dhara Shah
  • Publication number: 20170289806
    Abstract: The proliferation of IOT devices has led to an increase in sensitive, cloud-stored data. To provide further protection, IOT device data may be secured by geographically based access controls as a supplement to or in place of traditional password protection. A geographically based access control restricts data accessibility to designated geographical areas. In this manner, a requesting device may not access geo-fence protected IOT device data unless the requesting device is located within a designated geographical area. Geo-fence parameters utilized for creation of a geo-fence policy may be pre-specified or generated based on operating conditions. For example, a user may provide location data, such as an address or geographical coordinate, and a radial distance from the location for which data access is permissible. Additionally, geo-fence parameters can be automatically determined based on criteria such as an IOT device type or data usage characteristics.
    Type: Application
    Filed: March 31, 2016
    Publication date: October 5, 2017
    Inventors: Dhiraj Girdhar, Kevin Meehan, Brian Christopher Peck, Dhara Shah
  • Patent number: 9781602
    Abstract: The proliferation of IOT devices has led to an increase in sensitive, cloud-stored data. To provide further protection, IOT device data may be secured by geographically based access controls as a supplement to or in place of traditional password protection. A geographically based access control restricts data accessibility to designated geographical areas. In this manner, a requesting device may not access geo-fence protected IOT device data unless the requesting device is located within a designated geographical area. Geo-fence parameters utilized for creation of a geo-fence policy may be pre-specified or generated based on operating conditions. For example, a user may provide location data, such as an address or geographical coordinate, and a radial distance from the location for which data access is permissible. Additionally, geo-fence parameters can be automatically determined based on criteria such as an IOT device type or data usage characteristics.
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: October 3, 2017
    Assignee: CA, Inc.
    Inventors: Dhiraj Girdhar, Kevin Meehan, Brian Christopher Peck, Dhara Shah
  • Publication number: 20170273937
    Abstract: A composition which includes Phenylalanine, Serine, Glutamine and GABA (?-aminobutyric acid). The composition contains the essential amino acids Phenylalanine; Glutamine; the non-essential amino acid Serine; and GABA (?-aminobutyric acid) in concentrations effective to influence or modulate the neurotransmitter pentapeptide enkephalin. The composition may further comprise tetrahydrocannabinol (THC).
    Type: Application
    Filed: March 23, 2016
    Publication date: September 28, 2017
    Inventor: Kevin Meehan
  • Patent number: 9271983
    Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: March 1, 2016
    Assignee: BIOADATP, LLC
    Inventor: Kevin Meehan
  • Patent number: 9144542
    Abstract: A composition for promoting hair growth in humans can include at least three of the following ingredients: Pygeum Africanum, Serenoa Repens, Ganoderma Lucidum, Piper Methysticum, and Zinc. The amount by weight of the identified ingredients in a particular formulation may range from at least 5% to no more than 50% of the formulation.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: September 29, 2015
    Assignee: Kay Jay, LLC
    Inventor: Kevin Meehan
  • Patent number: 9095164
    Abstract: A food composition for consumption by mammals is designed to increase the production of glutathione peroxidase and superoxide dismutase. A serving of the food composition has a total weight and includes, in order of decreasing weight, a meat, a brassica vegetable, and brown rice.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: August 4, 2015
    Inventor: Kevin Meehan
  • Publication number: 20140234248
    Abstract: A composition for promoting hair growth in humans can include at least three of the following ingredients: Pygeum Africanum, Serenoa Repens, Ganoderma Lucidum, Piper Methysticum, and Zinc. The amount by weight of the identified ingredients in a particular formulation may range from at least 5% to no more than 50% of the formulation.
    Type: Application
    Filed: February 21, 2014
    Publication date: August 21, 2014
    Inventor: Kevin Meehan
  • Publication number: 20130261127
    Abstract: A composition can include a plurality of active ingredients such as pyruvate, niacin, riboflavin, lipoic acid, and amidated glycine. The concentration by weight of the first active ingredient (pyruvate) in the composition can be greater than the concentration by weight of each one of the other active ingredients. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Application
    Filed: May 30, 2013
    Publication date: October 3, 2013
    Inventor: Kevin Meehan
  • Publication number: 20130101704
    Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Application
    Filed: December 18, 2012
    Publication date: April 25, 2013
    Inventor: Kevin Meehan
  • Patent number: 8344032
    Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Grant
    Filed: October 1, 2010
    Date of Patent: January 1, 2013
    Inventor: Kevin Meehan
  • Publication number: 20110236535
    Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.
    Type: Application
    Filed: October 1, 2010
    Publication date: September 29, 2011
    Inventor: Kevin MEEHAN
  • Patent number: 7981406
    Abstract: A composition includes ascorbate, zinc gluconate, and tropocollagen factors including L-proline, glycine and L-lysine. The composition contains the ascorbate, tropocollagen factors and zinc gluconate in concentrations effective to accelerate the production of collagen proteins within at least one collagen-containing tissue of an animal when administered to the animal. The at least one collagen-containing tissue includes at least one of cartilage tissue, tendon tissue, ligament tissue, vitreous humor tissue, connective tissue, hair tissue, bone tissue, and corneal tissue.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: July 19, 2011
    Inventor: Kevin Meehan
  • Patent number: 7914774
    Abstract: A liquid solution for topical application to the skin of an animal consists of solutes and a solvent, where the solutes include ascorbate, tropocollagen factors, copper, and zinc gluconate. The tropocollagen factors include L-proline, glycine and L-lysine.
    Type: Grant
    Filed: January 15, 2010
    Date of Patent: March 29, 2011
    Inventor: Kevin Meehan
  • Publication number: 20100166883
    Abstract: A composition includes ascorbate, zinc gluconate, and tropocollagen factors including L-proline, glycine and L-lysine. The composition contains the ascorbate, tropocollagen factors and zinc gluconate in concentrations effective to accelerate the production of collagen proteins within at least one collagen-containing tissue of an animal when administered to the animal. The at least one collagen-containing tissue includes at least one of cartilage tissue, tendon tissue, ligament tissue, vitreous humor tissue, connective tissue, hair tissue, bone tissue, and corneal tissue.
    Type: Application
    Filed: March 12, 2010
    Publication date: July 1, 2010
    Inventor: Kevin Meehan